Identifying the shared genes and KEGG pathways of Resolvin D1-targeted network and osteoarthritis using bioinformatics

References

• Alcaraz MJ, Guillén MI, Ferrándiz ML. Emerging therapeutic agents in osteoarthritis. Biochem Pharmacol. 2019;165:4–16.
   PubMed Web of Science ®Google Scholar
• Spitaels D, Mamouris P, Vaes B, et al. Epidemiology of knee osteoarthritis in general practice: a registry-based study. BMJ open. 2020;10(1):e031734.
   PubMed Web of Science ®Google Scholar
• Litwic A, Edwards MH, Dennison EM, et al. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013;105():185–199.
   PubMed Web of Science ®Google Scholar
• Honvo G, Lengelé L, Charles A, et al. Role of collagen derivatives in osteoarthritis and cartilage repair: a systematic scoping review with evidence mapping. Rheumatol Ther. 2020;7(4):703–740.
   PubMed Web of Science ®Google Scholar
• Hodges PW, van den Hoorn W, Wrigley TV, et al. Increased duration of co-contraction of medial knee muscles is associated with greater progression of knee osteoarthritis. Manual ther. 2016;21:151–158.
   PubMedGoogle Scholar
• Ferreira I, Falcato F, Bandarra N, et al. Resolvins, protectins, and maresins: DHA-derived specialized pro-Resolving mediators, biosynthetic pathways, synthetic approaches, and their role in inflammation. Molecules (Basel, Switzerland). 2022;27(5):1677.
   PubMed Web of Science ®Google Scholar
• Wang P, Zhu C, Liu M, et al. The inhibiting effect of aspirin triggered-Resolvin D1 in non-canonical pyroptosis in rats with acute keratitis. Exp Eye Res. 2022;218:108938.
   PubMed Web of Science ®Google Scholar
• Yang M, Song XQ, Han M, et al. The role of resolvin D1 in liver diseases. Prostaglandins Other Lipid Mediat. 2022;106634. 10.1016/j.prostaglandins.2022.106634.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay R, Raghavan S, Rao GN. Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function. Redox Biol. 2017;12:438–455.
   PubMed Web of Science ®Google Scholar
• Eickmeier O, Fussbroich D, Mueller K, et al. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis. PloS one. 2017;12(2):e0171249.
   PubMed Web of Science ®Google Scholar
• Benabdoune H, Rondon EP, Shi Q, et al. The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis. Inflammation Res. 2016;65(8):635–645.
   PubMed Web of Science ®Google Scholar
• Barrett T, Troup DB, Wilhite SE, et al. NCBI GEO: archive for functional genomics data sets–10 years on. Nucleic Acids Res. 2011;39( Database issue):D1005–10.
   PubMed Web of Science ®Google Scholar
• Yu Y, Liu L, Hu LL, et al. Potential therapeutic target genes for systemic lupus erythematosus: a bioinformatics analysis. Bioengineered. 2021;12(1):2810–2819.
   PubMed Web of Science ®Google Scholar
• Liang F, Peng L, Ma YG, et al. Bioinformatics analysis and experimental validation of differentially expressed genes in mouse articular chondrocytes treated with IL-1β using microarray data. Exp Ther Med. 2022;23(1):6.
   PubMed Web of Science ®Google Scholar
• Hu M, Li Z, Qiu J, et al. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry. Bioengineered. 2021;12(1):5996–6009.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao M, Zhang Y. Identification of fibronectin 1 (FN1) and complement component 3 (C3) as immune infiltration-related biomarkers for diabetic nephropathy using integrated bioinformatic analysis. Bioengineered. 2021;12(1):5386–5401.
   PubMed Web of Science ®Google Scholar
• Hu M, Zou L, Lu J, et al. Construction of a 5-feature gene model by support vector machine for classifying osteoporosis samples. Bioengineered. 2021;12(1):6821–6830.
   PubMed Web of Science ®Google Scholar
• Huang Y, Yang DD, Li XY, et al. ZBP1 is a significant pyroptosis regulator for systemic lupus erythematosus. Ann Transl Med. 2021;9(24):1773.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Santos A, von Mering C, et al. STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. Nucleic Acids Res. 2016;44(D1):D380–4.
   PubMed Web of Science ®Google Scholar
• Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57.
   PubMed Web of Science ®Google Scholar
• Luo C, Li Y, Liang X, et al. Special electromagnetic field-treated water and far-infrared radiation alleviates lipopolysaccharide-induced acute respiratory distress syndrome in rats by regulating haptoglobin. Bioengineered. 2021;12(1):6808–6820.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
   PubMed Web of Science ®Google Scholar
• Jia A, Xu L, Wang Y. Venn diagrams in bioinformatics. Brief Bioinform. 2021;22(5).
   Web of Science ®Google Scholar
• Fei J, Liang B, Jiang C, et al. Luteolin inhibits IL-1β-induced inflammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model. Biomed Pharmacothe. 2019;109:1586–1592.
   PubMed Web of Science ®Google Scholar
• Yang T, Hui R, Nouws J, et al. Untargeted metabolomics analysis of esophageal squamous cell cancer progression. J Transl Med. 2022;20(1):127.
   PubMed Web of Science ®Google Scholar
• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet (London, England). 2012;380(9859):2163–2196.
   PubMed Web of Science ®Google Scholar
• Flegal KM, Kruszon-Moran D, Carroll MD, et al. Trends in obesity among adults in the United States, 2005 to 2014. Jama. 2016;315(21):2284–2291.
   PubMed Web of Science ®Google Scholar
• Lohmander LS, Englund PM, Dahl LL, et al. The long-term consequence of anterior cruciate ligament and meniscus injuries: osteoarthritis. Am J Sports Med. 2007;35(10):1756–1769.
   PubMed Web of Science ®Google Scholar
• Mandl LA. Osteoarthritis year in review 2018: clinical. Osteoarthritis Cartilage. 2019;27(3):359–364.
   PubMed Web of Science ®Google Scholar
• Ogden CL, Carroll MD, Lawman HG, et al. Trends in obesity prevalence among children and Adolescents in the United States, 1988-1994 through 2013-2014. Jama. 2016;315(21):2292–2299.
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. Regulation of NF-κB by TNF family cytokines. Semin Immunol. 2014;26(3):253–266.
   PubMed Web of Science ®Google Scholar
• Jimi E, Ghosh S. Role of nuclear factor-kappaB in the immune system and bone. Immunol Rev. 2005;208():80–87.
   PubMed Web of Science ®Google Scholar
• Zhang T, Ma C, Zhang Z, et al. NF-κB signaling in inflammation and cancer. MedComm. 2021;2(4):618–653.
   PubMedGoogle Scholar
• Jimi E, Fei H, Nakatomi C. NF-κB signaling regulates physiological and pathological chondrogenesis. Int J Mol Sci. 2019;20(24):6275.
   PubMed Web of Science ®Google Scholar
• Liao S, Zhou K, Li D, et al. Schisantherin A suppresses interleukin-1β-induced inflammation in human chondrocytes via inhibition of NF-κB and MAPKs activation. Eur J Pharmacol. 2016;780:65–70.
   PubMed Web of Science ®Google Scholar
• Perkins ND, Gilmore TD. Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ. 2006;13(5):759–772.
   PubMed Web of Science ®Google Scholar
• Huang J. Current developments of targeting the p53 signaling pathway for cancer treatment. Pharmacol Ther. 2021;220:107720.
   PubMed Web of Science ®Google Scholar
• Liu Y, Tavana O, Gu W. p53 modifications: exquisite decorations of the powerful guardian. J Mol Cell Biol. 2019;11(7):564–577.
   PubMed Web of Science ®Google Scholar
• Zhang XH, Xu XX, Xu T. Ginsenoside Ro suppresses interleukin-1β-induced apoptosis and inflammation in rat chondrocytes by inhibiting NF-κB. Chin J Nat Med. 2015;13(4):283–289.
   PubMed Web of Science ®Google Scholar
• Xu M, Feng M, Peng H, et al. Epigenetic regulation of chondrocyte hypertrophy and apoptosis through Sirt1/P53/P21 pathway in surgery-induced osteoarthritis. Biochem Biophys Res Commun. 2020;528(1):179–185.
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang Z, Li B, et al. Identification of microRNA‑363‑3p as an essential regulator of chondrocyte apoptosis in osteoarthritis by targeting NRF1 through the p53‑signaling pathway. Mol Med Rep. 2020;21(3):1077–1088.
   PubMed Web of Science ®Google Scholar
• Zhu X, Yang S, Lin W, et al. Roles of cell cyle regulators cyclin D1, CDK4, and p53 in knee osteoarthritis. Genet Test Mol Biomarkers. 2016;20(9):529–534.
   PubMed Web of Science ®Google Scholar
• Kim EK, Choi EJ. Compromised MAPK signaling in human diseases: an update. Arch Toxicol. 2015;89(6):867–882.
   PubMed Web of Science ®Google Scholar
• Landeros RV, Jobe SO, Aranda-Pino G, et al. Convergent ERK1/2, p38 and JNK mitogen activated protein kinases (MAPKs) signalling mediate catecholoestradiol-induced proliferation of ovine uterine artery endothelial cells. J Physiol. 2017;595(14):4663–4676.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Ming J, Li Y, et al. Surfactant protein D attenuates nitric oxide-stimulated apoptosis in rat chondrocyte by suppressing p38 MAPK signaling. Biochem Biophys Res Commun. 2018;495(1):526–532.
   PubMed Web of Science ®Google Scholar
• Tang F, Wang Y, Hemmings BA, et al. PKB/Akt-dependent regulation of inflammation in cancer. Semin Cancer Biol. 2018;48:62–69.
   PubMed Web of Science ®Google Scholar
• De Santis MC, Gulluni F, Campa CC, et al. Targeting PI3K signaling in cancer: challenges and advances. Biochim Biophys Acta. 2019;1871(2):361–366.
   Web of Science ®Google Scholar
• Sun K, Luo J, Guo J, et al. The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review. Osteoarthritis Cartilage. 2020;28(4):400–409.
   PubMed Web of Science ®Google Scholar
• Xue JF, Shi ZM, Zou J, et al. Inhibition of PI3K/AKT/mTOR signaling pathway promotes autophagy of articular chondrocytes and attenuates inflammatory response in rats with osteoarthritis. Biomed Pharmacothe. 2017;89:1252–1261.
   PubMed Web of Science ®Google Scholar